Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells

Journal of Neurochemistry

Volumn 66, Issue 4, 1996, Pages 1426-1431

  Fiebich, Bernd L ^a   Biber, Knut ^a   Gyufko, Kacin ^a   Berger, Mathias ^a   Bauer, Joachim ^a   Van Calker, Dietrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adenosine; Adenosine A2b receptor; Alzheimer's disease; Astrocytes; Interleukin 6

Indexed keywords

ANIMALIA;

8 (3 CHLOROSTYRYL)CAFFEINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8-(3-CHLOROSTYRYL)CAFFEINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR; ANTINEOPLASTIC AGENT; CAFFEINE; DRUG DERIVATIVE; INTERLEUKIN 6; MESSENGER RNA; XANTHINE DERIVATIVE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; BUCLADESINE; CAFFEINE DERIVATIVE; CYTOKINE; FORSKOLIN; INTERLEUKIN 1BETA; PHENYLISOPROPYLADENOSINE;

ARTICLE; ASTROCYTOMA; BLOOD; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; NORTHERN BLOTTING; STEREOISOMERISM; ULTRASTRUCTURE; ALZHEIMER DISEASE; ASTROCYTE; HUMAN CELL; IMMUNOREGULATION; MACROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANTINEOPLASTIC AGENTS; ASTROCYTOMA; BLOTTING, NORTHERN; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; STEREOISOMERISM; TUMOR CELLS, CULTURED; XANTHINES;

EID: 0029670366     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66041426.x     Document Type: Article

References (33)

1. Aloisi F., Care A., Borsellino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G., and Peschle C. (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 149, 2358-2366.
2. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Volk B., and Berger M. (1991) Interleukin-6 and alpha2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
3. Bauer J., Ganter U., Strauss S., Stadtmueller G., Frommberger U., Bauer H., Volk B., and Berger M. (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res. Immunol. 143, 650-657.
4. Bouma M. G., Stad R. K., van den Wildenberg F. A., and Buurman W. A. (1994) Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153, 4159-4168.
5. Cadman E. D., Naugles D. D., and Lee C.-M. (1994) cAMP is not involved in interleukin-1-induced interleukin-6 release from human astrocytoma cells. Neurosci. Lett. 178, 251-254.
6. Daly J. W. and Jacobson K. A. (1995), Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, pp. 155-160. Kluwer Academic Publishers, Boston.
7. Fiebich B. L., Lieb K., Berger M., and Bauer J. (1995) Stimulation of the sphingomyelin pathway induces IL-6 gene expression in human astrocytoma cells. J. Neuroimmunol. 63, 207-211.
8. 2b receptor signalling is altered by stimulation of bradykinin or interleukin receptors in astroglioma cells. Neurochem. Int. 25, 99-102.
9. Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden K T., Jacobson K. A., Leff P., and Williams M. (1994) VI. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143-156.
10. Frei K. and Fontana A. (1989) Physiology and disease, in Neuroimmune Networks, pp. 127-132. Alan R. Liss, New York.
11. Gebicke-Härter P., Christoffel F., Timmer J., Northoff H., Berger M., and van Calker D. (1996) Both adenosine A1- and A2-receptors are required to stimulate microglia proliferation. Neurochem. Int. (in press).
12. Grimaldi M., Pozzoli G., Navarra P., Preziosi P., and Schettini G. (1994) Vasoactive intestinal peptide and forskolin stimulate interleukin 6 production by rat cortical astrocytes in culture via a cyclic AMP-dependent, prostaglandin-independent mechanism. J. Neurochem. 63, 344-350.
13. Hama T., Miyamoto M., Tsukui H., Nishio C., and Hatanaka H. (1989) Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci. Lett. 104, 340-344.
14. Hindley S., Herman M. A., and Rathbone M. P. (1994) Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist. J. Neurosci. Res 38, 399-406.
15. Huell M., Strauss S., Volk B., Berger M., and Bauer J. (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to brains of Alzheimer's disease patients. Acta Neuropathol. (Berl.) 89, 544-551
16. Jacobson K. A., Nikodijevic O., Padgett W. L., Gallo-Rodriguez C., Maillard M., and Daly J. W. (1993) 8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett. 323, 141-144.
17. Lieb K., Kaltschmidt C., Kaltschmidt B., Baeuerle P. A., Berger M., Bauer J., and Fiebich B. L. (1996) Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor α genes in the human astrocytoma cell line U373. J. Neurochem. 66, 1496-1503.
18. Maeda Y., Matsumoto M., Hori O., Kuwabara K., Ogawa S., Yan S. D., Ohtsuki T., Kinoshika T., Kamada T., and Stern D. M. (1994) Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuronal survival. J. Exp. Med. 180, 2297-2308.
19. Magistretti P. J., Hof P. R., and Martin J. L. (1986) Adenosine stimulates glycogenolysis in mouse cerebral cortex: a possible coupling mechanism between neuronal activity and energy metabolism. J. Neurosci. 6, 2558-2562.
20. Maimone D., Cioni C., Rosa S., Macchia G., Aloisi F., and Annunziata P. (1993) Norepmephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1β and TNFα. J. Neuroimmunol. 47, 73-82.
21. McGeer P. L., Kawamata T., Walker D. G., Akiyama H., Tooyama I., and McGeer E. G. (1993) Microglia in degenerative neurological disease. Glia 7, 84-92.
22. Mortimer J. (1991) Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-controlled studies. Int. J. Epidemiol. 20, 28-38.
23. Nonaka H , Ichimura M., Takeda M., Nonaka Y., Shimada J., Suzuki F., Yamaguchi K., and Kase H. (1994a) KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine), a potent and selective adenosine A2 receptor antagonist. Eur. J. Pharmacol. 267, 335-341.
24. 3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes. Mol. Pharmacol. 46, 817-822.
25. Norris G. J. and Benveniste E. N. (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J. Neuroimmunol. 45, 137-146.
26. Rathbone M. P., Middlemiss P. I., Kim J. K., Gysbers J. W., DeForge S. P., Smith R. W., and Hughes D. W. (1992) Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells. Neurosci. Res. 13, 1-17.
27. Reinstein L. J., Lichtman S. N., Currin R. T., Wang J., Thurman R. G., and Lemasters J. J. (1994) Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells. Hepatology 19, 1445-1452.
28. Royston C. M., Rothwell N. J., and Roberts G. W. (1992) Alzheimer's disease: pathology to potential treatments? Trends Pharmacol. Sci. 13, 131-133.
29. Rudolphi K. A., Schubert P., Parkinson F. E., and Fredholm B. B. (1992) Neuroprotective role of adenosine in cerebral ischemia. Trends Pharmacol. Sci. 13, 439-445.
30. Schöbitz B., Ron de Kloet E., and Holsboer F. (1994) Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol 44, 397-432.
31. van Calker D., Müller M., and Hamprecht B. (1979) Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33, 999-1005.
32. Williams M. (1995) Purinoceptors in central nervous system function, in Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds), pp. 643-655. Raven Press, New York.
33. Wood J. A., Wood P. L., Ryan R., Graff Radford N. R., Pilapil C., Robitaille Y., and Quirion R. (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.